chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a nurse and refers to an unspecified number of patients of unspecified age and gender. The patients medical and concurrent condition were not reported. On an unspecified date, the unspecified number of patients were administered with improperly stored doses of LIQUID PEDVAXHIB (lot K011077, expiry date: 30-MAR-2017; lot K015462, expiry date: 10-JUL-2017; lot K019701, expiry date: 17-JUL-2017; lot L002866, expiry date: 10-NOV-2017; lot L012838, expiry date: 10-MAR-2018). No adverse effects were reported. This is one of the several reports from the same reporter. Additional information has been requested.
Subsequent to receiving the second dose of haemophilus b conjugate vaccine + hepatitis b vaccine recombinant (yeast) the pt experienced swelling and redness near injection site that was larger than normal.  Medical attention was sought. No further information is available.
COVID-19 symptoms started 06/17/22; tested positive 06/17/22. I had mild congestion and fairly significant fatigue. The congestion was for 4 days and the fatigue was for 4 days and persisted for 10 days. I was exposed and got Covid and we flew home and driving from from airport that night I started having symptoms. We stopped and got home tests and a number of us from the trip were positive. I still feel a bit tired but I am working. I also took Paxlovid starting the 18th. I still don't have the endurance like I did before.
9 x 11 cm surrounding erythema, warmth, and tenderness (started noon on 10/15/13). Started on antibiotics (AUGMENTIN).
Soreness in his arm after all three shots; Could not lift shoulder for a day and a half; Soreness in his shoulder; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Soreness in his arm after all three shots), MOBILITY DECREASED (Could not lift shoulder for a day and a half) and ARTHRALGIA (Soreness in his shoulder) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02AL20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CLONAZEPAM (KLONOPIN) for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Soreness in his arm after all three shots), MOBILITY DECREASED (Could not lift shoulder for a day and a half) and ARTHRALGIA (Soreness in his shoulder). At the time of the report, PAIN IN EXTREMITY (Soreness in his arm after all three shots), MOBILITY DECREASED (Could not lift shoulder for a day and a half) and ARTHRALGIA (Soreness in his shoulder) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No treatment details were reported.   This case was linked to MOD-2021-359056, MOD-2021-359053.   Most recent FOLLOW-UP information incorporated above includes: On 22-Oct-2021: Patient date of birth updated and new reporter added.
Nose started running really bad and he broke out into hives all over his body. He had really swelled up ones on his legs and about 25 just on his back. He had about a total of 40 hives on his body.
They actually did admitted me to the hospital (further clarification unknown), did all cardiac stuff; Fatigue; Headache; Ringing in my ear; Flashed face; Fluctuation with my blood pressure and heart rate; Fluctuation with my blood pressure and heart rate; I have chest pressure; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 22Mar2021 (Batch/Lot number was not reported) as 1st dose, single for covid-19 immunisation. Medical history and concomitant medications were not reported. On an unspecified date, the patient had the typical fatigue, headache, ear ringing and flashed face that lasted a couple days. And about few days after (unspecified date), the patient had fluctuation with blood pressure and heart rate and chest pain. It was reported that the patent was actually admitted to the hospital (further clarification unknown), did all cardiac stuff and everything was okay. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
No further AE's were reported; an expired dose of GARDASIL 9; Information has been received from a nurse manager, referring to a patient of unknown age and gender. Information about medical history, concurrent condition and concomitant therapy was unknown.   On 04-FEB-2022, the patient was vaccinated with an expired dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (0.5 ml one time, lot # 1614898, expiration date 15-NOV-2021; strength and route unknown) for prophylaxis (expired product administered). Vaccine had not undergone a temperature excursion. No further adverse events were reported.
Severe itchiness from the waist up - head, behind ears, throat, shoulders, back and chest
NUMBNESS IN CHEEKS; TINGLING PINS AND NEEDLES; GROGGY; FELT GROSS; SWEATY; NAUSEA; VERY TIRED; HEADACHE; CHILLS AND FEVERS; This spontaneous report received from a patient concerned a 27 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A264, expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 13:30 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021 22:00, the subject experienced chills and fevers. On 10-APR-2021, the subject experienced sweaty. On 10-APR-2021, the subject experienced nausea. On 10-APR-2021, the subject experienced very tired. On 10-APR-2021, the subject experienced headache. On 10-APR-2021 10:00, the subject experienced groggy. On 10-APR-2021 10:00, the subject experienced felt gross. On 11-APR-2021 22:00, the subject experienced tingling pins and needles. On 12-APR-2021, the subject experienced numbness in cheeks. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sweaty, groggy, felt gross, nausea, and headache, and chills and fevers on 10-APR-2021, had not recovered from tingling pins and needles, and very tired, and the outcome of numbness in cheeks was not reported. This report was non-serious.
Debilitating pain in all ligaments, muscles beginning morning after vaccines and continuing stiffness-more on left side but all over body not much improved in 2 months, if at all-affects all joints. On April 4 unable to cross (R) leg over (L).
At 11:15 am, 49 years old, female complained of feeling dizziness and tightness in the chest. Patient has a history of Asthma. No known allergies. Vitals signs taken 11:15 am 113/82 BP, HR 84, RR 18, OS at 100 %. Patient will be observed for 30 minutes. Patient had water and a breakfast bar. 11:30 am vitals BP 110/78, HR 72, RR 16, OS at 100 %. Patient stated that she was feeling better. Patient was breathing normal with no signs of distress. Patient was discharged with family.
Information has been received from a registered nurse referring to a patient of unknown age and gender. There was no pertinent medical history, concomitant medication or drug allergies/drug reactions reported. On 22-SEP-2015, the patient was vaccinated with ZOSTAVAX (0.65 ml, Lot #L024997, expiration date: 06-OCT-2016), which were improperly stored for 8 days. The outcome was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
Temperature over 102, nausea, joint and muscle pain, no energy, no appetite for more than 24 hours.
Information has been received from a healthcare worker concerning a 73 year old female who on 20-DEC-2010 was vaccinated intramuscularly with a 0.5 ml dose of PNEUMOVAX 23 (lot # 667271/0880Z). On an unspecified date the patient experienced redness, swelling and warmth at the injection site (on the arm). At the time of the report, the patient's status was unknown. The patient sought medical attention by office visit. The physician was not comfortable using the remaining doses of PNEUMOVAX 23. The reporter requested a lot check. A lot check has been initiated. This is one of several reports received from the same source. A standard lot check investigation has been finalized. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. Additional information has been requested.
swelling under the left eye; slight swelling of her upper eyelid; This spontaneous case was reported by an other health care professional and describes the occurrence of EYE SWELLING (swelling under the left eye) and SWELLING OF EYELID (slight swelling of her upper eyelid) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Long QT. Concurrent medical conditions included Allergy NOS (common allergies). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EYE SWELLING (swelling under the left eye) and SWELLING OF EYELID (slight swelling of her upper eyelid). The patient was treated with LORATADINE (CLARITINE) for Swelling, at a dose of Claritin at night; FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) for Swelling, at a dose of Flonase in the morning, one spray in each nostril; CORTISONE for Swelling, at a dose of Cortisone cream and PARACETAMOL (TYLENOL) for Swelling, at a dose of 1 UNK. At the time of the report, EYE SWELLING (swelling under the left eye) and SWELLING OF EYELID (slight swelling of her upper eyelid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Relevant concomitant medications also included natarol. Patient experienced swelling under the left eye which progressed to her left upper eyelid. 4-5 days later the right eyelid and under the right eye started to swell.She had seen a physician where they did a throat culture, covid test, blood work and immunology studies.
Rash, 2.4 inches diameter, itchy. Recommended ice, hydrocortisone cr. Anti histamine.
Localized pain at site of injection with difficulty lifting arm. Also, 2 week myalgias and arthralgias throughout body. Symptoms resolved after 2 weeks.
Information has been received from a physician concerning a 17-month-old male with no pre-existing allergies, birth defects, or medical conditions who on 28-APR-2006 was vaccinated SC in the left arm with a first dose of Varivax (Lot # 652803/0262F). There was no illness at the time of vaccination. On 06-OCT-2006 the patient was seen with a fever of 101.8 and a rash. It was noted that the patient had croup on 04-OCT-2006. There was no known exposure to chickenpox. The patient had 2 skin papules on her back, and one on each of the following places: her left flank, right abdomen, right cheek, back of right knee, and forehead. Her diagnosis were: thrush (treated with DIFLUCAN); chickenpox (plan was to treat symptoms): and fever (CBC was noted to be viral). The outcome was recovered. Additional information has been requested.
Information has been received from a physician who cares for the patient's grandmother, concerning a female patient who was vaccinated with a dose of measles virus vaccine live. The physician reported that the female patient broke out in a rash while playing with her grandmother and the patient was seen by her pediatrician. It was noted that the patient's grandmother is post kidney transplant and therefore she sought medical attention as she was concerned with the possibility that she could contact a vaccine virus. There was no product quality complaint reported. Follow-up information received on 18-Jan-2006 from a physician reported that the patient did not have a "reaction". The physician only questioned whether the patient who developed a rash, could shed virus to an immunocompromised family member. Additional information indicated that the immunocompromised grandmother did not develop an adverse event. It was noted that her grandmother was vaccinated with a dose of measles virus vaccine live and developed a rash. No additional information has been requested.
Upon awakening, exhausted feeling, severe weakness, total body aches, chills, temp 97.4 orally, slight nausea. Notified supervisor at work, took Tylenol 1000 mg and slept for 2.5 hours. Woke up with symptoms much reduced and went to work
A non-serious spontaneous report of child had a bloody nose following FLUMIST has been received from a physician concerning a 36-month-old male, subsequent to FLUMIST. This case will be submitted in accordance with MedImmune's FLUMIST post-marketing commitment for the indicated population of 2 years to 59 months of age. Neither medical history nor concomitant medication was reported for this patient. On 09-Dec-2010, the patient received FLUMIST. One to two to minutes after receiving FLUMIST, the patient experienced a bloody nose. The outcome of the event of child had a bloody nose following FLUMIST was unknown.
4 1/2 hours of severe body tremors and spasms, accompanied by chills. Followed by severe migraine, bodyaches and fever.  Vomiting and diarrhea began approximately 9:00 AM on April 2, and lasted six hours. Extreme exhaustion and weakness continued until approximately 12 o?clock noon on April 3.
sz 8PM eyes rolled back & began to shake lasted 30sec to 1 min; fever 103 30mins to 1 hrs p/vax; tx MD gave Tempra & APAP for fever-directions to monitor & follow-up w/MD
The nursing administering the vacinnation diluted the vaccine with 1 ml rather than 1.8 ml as recommended.  The dose administered was higher than recommended.
Redness, warmth, induration at site of vaccination approx 3cm X 5cm, (R) deltoid at noon on 8/11/10.
Developed significant pain within 24 to 48 hrs. of vaccine administration. Developed paresthesias, weakness, loss of function of 1st & 2nd fingers.
Fever 104.5, tachycardia 135, Chills, headache,. after a week. developed rash on neck, head, and face. Still present.  spine pain  Decreased cognition
had a rash at the injection side, pretty wide, warm and inflamed; had a rash on both arms where their elbow is, where the arm bends; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (had a rash at the injection side, pretty wide, warm and inflamed) and RASH (had a rash on both arms where their elbow is, where the arm bends) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     Concomitant products included ESTRADIOL (ESTROGEN) and PROGESTERONE for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced RASH (had a rash on both arms where their elbow is, where the arm bends). On 23-Mar-2021, the patient experienced INJECTION SITE RASH (had a rash at the injection side, pretty wide, warm and inflamed). The patient was treated with CLOBETASOL PROPIONATE (topical) for Allergic reaction, at an unspecified dose and frequency. At the time of the report, INJECTION SITE RASH (had a rash at the injection side, pretty wide, warm and inflamed) and RASH (had a rash on both arms where their elbow is, where the arm bends) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
burping; insomnia; look down on arm and it started itching; nasal symptoms, green mucus that ent down the throat as it was an allergic reaction; arm really sore and couldnot lay on that arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm really sore and couldnot lay on that arm), ERUCTATION (burping), INSOMNIA (insomnia), VACCINATION SITE PRURITUS (look down on arm and it started itching) and NASAL DISCHARGE DISCOLOURATION (nasal symptoms, green mucus that ent down the throat as it was an allergic reaction) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011G25A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced VACCINATION SITE PAIN (arm really sore and couldnot lay on that arm). On an unknown date, the patient experienced ERUCTATION (burping), INSOMNIA (insomnia), VACCINATION SITE PRURITUS (look down on arm and it started itching) and NASAL DISCHARGE DISCOLOURATION (nasal symptoms, green mucus that ent down the throat as it was an allergic reaction). At the time of the report, VACCINATION SITE PAIN (arm really sore and couldnot lay on that arm) and ERUCTATION (burping) had resolved and INSOMNIA (insomnia), VACCINATION SITE PRURITUS (look down on arm and it started itching) and NASAL DISCHARGE DISCOLOURATION (nasal symptoms, green mucus that ent down the throat as it was an allergic reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Received Moderna vaccine on 05/21/2021.  On 05/23/2021 upon awakening at 6 am both arms at the shoulder joints and upper arm muscles were extremely sore. I had limited movement in both arms although I received injection in left arm only.   The soreness lasted for about 2 weeks and subsided entirely by the time I was to receive my second Injection.  On 06/18/2021 I received my second  Moderna Injection and on 06/19/2021 both of my upper arms ached severely and were immobile. I couldn't lift a fork to eat or a cup of coffee.  It is now 06/23 and my upper arm muscles and shoulder joints are in excruciating pain and I still have limited movement due to sore muscles and joints. I have a Dr's. appointment tomorrow to get some relief.
Hot sweaty thirsty Slight nausea At night whole body chills Whole body shivers Fever
Patient was seen at clinic on 5-18-11. Clinic MD diagnosed him with swelling and redness below the Tdap and is warm to the touch. He also was diagnosed with cellulitis.
Covered in bumps; Unusual growth on their left leg; Developed a localized rash the size of a half dollar on my stomach that spread over my entire body; Developed flu like symptoms, "similar to flu but 10x worse then any flu I ever had"; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Developed flu like symptoms, "similar to flu but 10x worse then any flu I ever had"), RASH PAPULAR (Covered in bumps), LIMB MASS (Unusual growth on their left leg) and RASH (Developed a localized rash the size of a half dollar on my stomach that spread over my entire body) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044B21A and 045A21A) for COVID-19 vaccination.     No medical history was provided.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (Developed flu like symptoms, "similar to flu but 10x worse then any flu I ever had") and RASH (Developed a localized rash the size of a half dollar on my stomach that spread over my entire body). On an unknown date, the patient experienced RASH PAPULAR (Covered in bumps) and LIMB MASS (Unusual growth on their left leg). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form and PREDNISONE at a dose of 1 dosage form. On 22-Apr-2021, INFLUENZA LIKE ILLNESS (Developed flu like symptoms, "similar to flu but 10x worse then any flu I ever had") had resolved. On 09-Jul-2021, LIMB MASS (Unusual growth on their left leg) had resolved. At the time of the report, RASH PAPULAR (Covered in bumps) outcome was unknown and RASH (Developed a localized rash the size of a half dollar on my stomach that spread over my entire body) had not resolved. Not Provided          Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Treatment medication Prednisone has been added. Events are added: covered in bumps, unusual growth on their left leg
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient's medical history and current conditions were not provided. On 13-JUN-2015, the patient was inadvertently vaccinated with a dose of ZOSTAVAX (lot #, expiration date, dose and route were not reported) instead of VARIVAX (Merck). No adverse experience was reported. There was no product quality complaint (PQC) involved. Additional information has been requested.
STING IN THE AREA OF THE LEFT KIDNEY, ACHINESS AND PAIN IN THE LEFT SIDE OF THE BODY (ALMOST LIKE A BACK PAIN AND PAIN CONTINUED ON AND OFF FOR 1 DAY); TINGLING SENSATION ON THE LEFT SIDE OF BODY; LETHARGY; This spontaneous report received from a patient concerned a 52 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included a benign tumor in left kidney (known as angiomyolipoma), high blood pressure, and pre-diabetic. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802072, expiry: UNKNOWN) dose was not reported, administered on 08-MAR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported. On 08-MAR-2021, the subject experienced sting in the area of the left kidney, achiness and pain in the left side of the body (almost like a back pain and pain continued on and off for 1 day). On 08-MAR-2021, the subject experienced tingling sensation on the left side of body. On 08-MAR-2021, the subject experienced lethargy. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sting in the area of the left kidney, achiness and pain in the left side of the body (almost like a back pain and pain continued on and off for 1 day) on 15-MAR-2021, and lethargy on 10-MAR-2021, and the outcome of tingling sensation on the left side of body was not reported. This report was non-serious.
pains/ Aches; Loss of taste; Loss of smell; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pains/ Aches), AGEUSIA (Loss of taste) and ANOSMIA (Loss of smell) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 11-Mar-2021, the patient experienced AGEUSIA (Loss of taste) and ANOSMIA (Loss of smell). On an unknown date, the patient experienced PAIN (pains/ Aches). At the time of the report, PAIN (pains/ Aches), AGEUSIA (Loss of taste) and ANOSMIA (Loss of smell) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment information was not provided.